NUMBER min allows vivo study technetium radiopharmaceuticals positron emission tomography pet pet provides quantitative assay radioactivity excellent temporal spatial resolution revealing biodistributions previously available vitro assay methods produced proton irradiation natural molybdenum NUMBER mev cyclotron extracted electrochemical etching technique prepared make myocardial perfusion agent teboroxime identical manner increased absorbed radiation dose requires sevenfold reduction administered activity compared clinical pet studies performed visually compared clearance approximately NUMBER min peak myocardial extraction approximately NUMBER injected dose heart results confirm potential 94mtc pet quantitatively studying pharmacokinetics new old technetium agents man technetium 94m technetium 94m technetium 94m pertechnetate 99mtco4 99mtc teboroxime 13n ammonia half time 94mtc teboroxime NUMBER g t1 NUMBER